Cemindo Gemilang Tbk PT
IDX:CMNT
Cemindo Gemilang Tbk PT
IDX:CMNT
Price:
825
IDR
-6.25%
Market Closed
Market Cap:
14.1T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
CMNT Alert
Cemindo Gemilang Tbk PT
825
-55 (-6.25%)
| 52 Week Range |
750
950
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
Delete Alert
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Cemindo Gemilang Tbk PT
Cemindo Gemilang Tbk PT
| Current Assets | 3.7T |
| Cash & Short-Term Investments | 435.4B |
| Receivables | 949.9B |
| Other Current Assets | 2.3T |
| Non-Current Assets | 13.2T |
| Long-Term Investments | 43.6B |
| PP&E | 12.8T |
| Other Non-Current Assets | 368.8B |
| Current Liabilities | 7.1T |
| Accounts Payable | 1.9T |
| Accrued Liabilities | 423.3B |
| Short-Term Debt | 2.1T |
| Other Current Liabilities | 2.7T |
| Non-Current Liabilities | 7.2T |
| Long-Term Debt | 6.2T |
| Other Non-Current Liabilities | 979.8B |
Balance Sheet
Cemindo Gemilang Tbk PT
Cemindo Gemilang Tbk PT
Currency: IDR
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
205 824
|
293 180
|
399 867
|
449 569
|
486 200
|
545 114
|
640 498
|
|
| Cash |
205 824
|
293 180
|
230 160
|
310 190
|
272 095
|
266 262
|
290 021
|
|
| Cash Equivalents |
0
|
0
|
169 707
|
139 379
|
214 105
|
278 852
|
350 477
|
|
| Short-Term Investments |
235 665
|
200 997
|
9 844
|
0
|
222 992
|
0
|
3 075
|
|
| Total Receivables |
1 423 549
|
1 649 458
|
1 031 574
|
886 162
|
836 686
|
1 133 116
|
912 819
|
|
| Accounts Receivables |
981 585
|
1 066 031
|
845 915
|
779 670
|
719 632
|
1 028 073
|
714 364
|
|
| Other Receivables |
441 964
|
583 427
|
185 659
|
106 492
|
117 054
|
105 043
|
198 455
|
|
| Inventory |
1 235 619
|
1 421 843
|
1 401 083
|
1 663 574
|
1 887 723
|
1 763 473
|
1 760 034
|
|
| Other Current Assets |
187 893
|
240 058
|
636 657
|
464 162
|
254 814
|
418 386
|
132 909
|
|
| Total Current Assets |
3 288 550
|
3 805 536
|
3 479 025
|
3 463 467
|
3 465 423
|
3 860 089
|
3 449 335
|
|
| PP&E Net |
13 282 662
|
14 977 612
|
15 078 167
|
14 720 015
|
14 324 520
|
13 726 101
|
13 304 550
|
|
| PP&E Gross |
13 282 662
|
14 977 612
|
15 078 167
|
14 720 015
|
14 324 520
|
13 726 101
|
13 304 550
|
|
| Accumulated Depreciation |
5 040 004
|
5 501 368
|
6 280 697
|
7 104 000
|
8 049 093
|
8 595 238
|
9 334 353
|
|
| Intangible Assets |
8 706
|
6 120
|
4 304
|
2 795
|
1 695
|
0
|
0
|
|
| Note Receivable |
167 960
|
193 236
|
189 284
|
199 301
|
68 173
|
60 173
|
71 166
|
|
| Long-Term Investments |
4 762
|
4 757
|
4 752
|
4 744
|
4 737
|
4 730
|
40 421
|
|
| Other Long-Term Assets |
892 642
|
620 852
|
287 808
|
245 784
|
268 539
|
304 891
|
238 876
|
|
| Total Assets |
17 645 282
N/A
|
19 608 113
+11%
|
19 043 340
-3%
|
18 636 106
-2%
|
18 133 087
-3%
|
17 955 984
-1%
|
17 104 348
-5%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1 076 305
|
852 059
|
1 322 292
|
1 348 293
|
1 499 525
|
1 793 085
|
1 938 950
|
|
| Accrued Liabilities |
342 687
|
417 730
|
209 227
|
393 753
|
287 965
|
380 797
|
406 317
|
|
| Short-Term Debt |
1 827 791
|
1 730 216
|
2 107 511
|
2 441 053
|
2 541 747
|
2 598 923
|
2 444 396
|
|
| Current Portion of Long-Term Debt |
577 170
|
634 203
|
1 099 907
|
1 204 694
|
2 318 351
|
1 415 162
|
1 843 748
|
|
| Other Current Liabilities |
3 575 329
|
4 583 096
|
3 431 540
|
2 581 173
|
1 688 849
|
1 770 498
|
2 158 590
|
|
| Total Current Liabilities |
7 399 282
|
8 217 304
|
8 170 477
|
7 968 966
|
8 336 437
|
7 958 465
|
8 792 001
|
|
| Long-Term Debt |
6 344 845
|
5 648 258
|
6 297 250
|
6 310 390
|
5 654 931
|
5 547 531
|
4 534 502
|
|
| Deferred Income Tax |
156 400
|
216 567
|
75 342
|
213 004
|
221 147
|
375 846
|
523 944
|
|
| Minority Interest |
348 367
|
420 521
|
335 725
|
321 397
|
359 873
|
342 314
|
321 126
|
|
| Other Liabilities |
396 564
|
2 182 522
|
1 760 241
|
94 893
|
80 252
|
92 381
|
102 774
|
|
| Total Liabilities |
14 645 458
N/A
|
16 685 172
+14%
|
16 639 035
0%
|
14 908 650
-10%
|
14 652 640
-2%
|
14 316 537
-2%
|
14 274 347
0%
|
|
| Equity | ||||||||
| Common Stock |
4 438 000
|
4 438 000
|
5 544 352
|
8 562 752
|
8 562 752
|
8 562 752
|
8 562 752
|
|
| Retained Earnings |
3 628 522
|
3 686 672
|
3 217 114
|
2 978 660
|
3 068 416
|
2 915 730
|
3 626 884
|
|
| Additional Paid In Capital |
1 406 696
|
1 406 696
|
236 984
|
1 653 900
|
1 653 900
|
1 653 900
|
1 653 900
|
|
| Other Equity |
783 650
|
764 917
|
159 917
|
202 736
|
359 989
|
353 675
|
451 967
|
|
| Total Equity |
2 999 824
N/A
|
2 922 941
-3%
|
2 404 305
-18%
|
3 727 456
+55%
|
3 480 447
-7%
|
3 639 447
+5%
|
2 830 001
-22%
|
|
| Total Liabilities & Equity |
17 645 282
N/A
|
19 608 113
+11%
|
19 043 340
-3%
|
18 636 106
-2%
|
18 133 087
-3%
|
17 955 984
-1%
|
17 104 348
-5%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
17 126
|
17 126
|
17 126
|
17 126
|
17 126
|
17 126
|
17 126
|
|
Switch to:
Switch to:
See Also
Discover More
